Gurdane Bhutani

Venture investor in New York City

Invests in AI

AI is one of the sectors on Gurdane Bhutani's investor profile, next to Healthcare & Biotech and Biotech & Pharma, at seed. The record holds 9 deals, including Atlas Health, Junction Health and Freedom Biosciences.

Email Investor

Email Investor

Credits to line up before a seed round

Gurdane Bhutani backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Atlas Health
  • Junction Health
  • Freedom Biosciences
  • Juniper Genomics
  • CareRev
  • Thesis
  • Vivodyne
  • Persist AI
  • Contraline, Inc.

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma
Rounds
Seed
Profile
Venture investor
Deals on record
9
Based in
New York City, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Gurdane Bhutani invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Gurdane Bhutani's investor profile, together with Healthcare & Biotech and Biotech & Pharma. The stages on record are seed.
Which companies has Gurdane Bhutani backed?
The record lists 9 deals, including Atlas Health, Junction Health, Freedom Biosciences, Juniper Genomics and CareRev. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Gurdane Bhutani?
For a company raising a seed round, AI Perks lists credits such as Redis (up to $10,000), Modal (up to $50,000), Algolia (up to $10,000) and NVIDIA (up to Varies), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor